fashion -WSS

fashion

author：knowledge 2025-10-01 22:49:18 - browse：5332

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

WSS

STAT Readout Newsletter: Today's biggest biotech updates

Why workplace violence is so common in health care

The EU Joint Clinical Assessment needs to live up to its promise

At least 12 people were injured in a blast at a port in northwest Turkey

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

At least 12 people were injured in a blast at a port in northwest Turkey

focus

fashion

focus

Cancer drug shortages should be causing more outrage

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Trump demands the U.S. pay no more for drugs than other countries … again

NYC plans to house migrants on an island in the East River

State Dept. review finds Biden bears some blame for Afghanistan failures

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Activists slam private health insurers over coverage restrictions

Pharmacists can make shortage drugs, but at what cost?

Medical leaders decry Supreme Court decision on affirmative action

In medicine, common shorthands can shortchange care

hotspot

Studies point to risks of excluding people with obesity from drug trials

First Opinion Podcast: Long Covid needs a new approach

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

STAT Summit: GSK CEO on pharma giant's new direction

Why workplace violence is so common in health care

CEOs share strategies for surviving biotech slump

entertainment

focus

entertainment

focus